Preclinical toxicology of platinum analogues in dogs

Intracarotid infusion of PCNU (NSC: 9546

Intracarotid infusion of PCNU (NSC: 95466): Preclinical toxicological study in dogs

✍ Liliana Goumnerova; Michael T. Richard; David Addison; Vital Montpetit; David J. 📂 Article 📅 1987 🏛 Springer US 🌐 English ⚖ 329 KB

Preclinical toxicology and tissue platin

Preclinical toxicology and tissue platinum distribution of novel oral antitumour platinum complexes: ammine/amine platinum(IV) dicarboxylates

✍ McKeage, Mark J.; Morgan, Sarah E.; Boxall, Francis E.; Murrer, Barry A.; Hard, 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 751 KB

A Comprehensive Guide to Toxicology in P

A Comprehensive Guide to Toxicology in Preclinical Drug Development || Preclinical Toxicology of Vaccines

✍ Green, Martin David 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 435 KB

*A Comprehensive Guide to Toxicology in Preclinical Drug Development* is a resource for toxicologists in industry and regulatory settings, as well as directors working in contract resource organizations, who need a thorough understanding of the drug development process. Incorporating real-life case

A Comprehensive Guide to Toxicology in P

A Comprehensive Guide to Toxicology in Preclinical Drug Development || Development of Preclinical Formulations for Toxicology Studies

✍ Boersen, Nathan 📂 Article 📅 2013 🏛 Elsevier ⚖ 673 KB

Improving methods for ECG recording in d

Improving methods for ECG recording in dog toxicology studies: Suggestions based on the review of 100 preclinical projects

✍ Pierre Paul Lainee; Jason Schofield; Claire Grant; Katherine Elliott; Clare Barn 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 51 KB

A Comprehensive Guide to Toxicology in P

A Comprehensive Guide to Toxicology in Preclinical Drug Development || Preclinical Development of Monoclonal Antibodies

✍ Meyer-Tamaki, Kathleen B. 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 865 KB

*A Comprehensive Guide to Toxicology in Preclinical Drug Development* is a resource for toxicologists in industry and regulatory settings, as well as directors working in contract resource organizations, who need a thorough understanding of the drug development process. Incorporating real-life case